Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Century Therapeutics, Inc.

NASDAQ: IPSC · Life Sciences · 3 alerts · CIK 1850119

Share price
$1.64Close, Nov 16
Market cap
$298M
Shares outstanding
181.6MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Century Therapeutics, Inc. filings on SEC EDGAR ↗

7:17 AM ET 8-K
Financial Results

Century Therapeutics Financial Results

Century Therapeutics reported third quarter 2026 financial results and provided updates on its iPSC-derived cell therapy pipeline. The company remains on track for an IND submission for CNTY-813 in Q4 2026 and expects its CD19-targeted CAR-iT cell therapy, CNTY-308, to enter the clinic by the end of 2026.

“We remain focused on disciplined execution as we rapidly advance our two potentially transformational programs, including CNTY-813, which has the potential to be a functional cure for type 1 diabetes, toward the clinic over the coming months.”

Brent Pfeiffenberger, Pharm.D., Chief Executive Officer of Century Therapeutics

“With general alignment reached with the FDA for both programs, we remain on track this year for clinical entry of CNTY-308 and IND submission of CNTY-813, positioning us for an important transition to clinical execution in 2027.”

Brent Pfeiffenberger, Pharm.D., Chief Executive Officer of Century Therapeutics
7:07 AM ET 10-Q
Financial Results

Century Therapeutics Q3 2026 Results: Net Loss of $23.5M, Loss Narrows

Century Therapeutics reported a total asset increase to $262.6 million as of September 30, 2026, driven by a significant increase in common stock issuance and long-term investments. The company's accumulated deficit grew to $871.6 million, reflecting ongoing development costs for its iPSC-derived immune cell therapies.

Key figure
Net loss $23.5M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.